Peanut allergy is one of the most serious food allergies and can lead to sudden, life-threatening reactions. Researchers from ...

The investigational monoclonal antibody, VYD2311, (Invivyd) met all primary and key secondary endpoints in the phase 3 LIBERTY study. It showed safety and tolerability superior to an mRNA-based ...

Invivyd reported statistically significant Phase 3 safety and tolerability results for VYD2311 compared with an mRNA-based COVID-19 vaccine and said it plans to pursue an Accelerated Approval BLA ...

VYD2311 met all primary and secondary endpoints comparing VYD2311 to an mRNA-based COVID-19 vaccine, demonstrating VYD2311 safety and tolerability that is clinically and statistically superior to the ...

Rice farmers and quarantine inspectors may soon have a powerful new weapon against one of the world’s most destructive rice diseases. A research team in China has developed two rapid diagnostic p ...

VYD2311 met all primary and secondary endpoints comparing VYD2311 to an mRNA-based COVID-19 vaccine, demonstrating VYD2311 safety and ...

Antibodies made by the immune system can sometimes target human brain cells, producing psychiatric symptoms. Researchers aim ...

Brelovitug (Mirum Pharmaceuticals) met the primary end point in the phase 3 portion of the phase 2b/3 AZURE-1 study in treatment-naive patients with chronic hepatitis delta virus ...

COVID-19 monoclonal antibody VYD2311 demonstrated favorable safety and tolerability compared with an mRNA-based COVID-19 vaccine in the Phas ...

Cancer antigens targeted by drug conjugates are restricted to the few membrane receptors (such as HER2 and TROP2) that ...

As flu and influenza-like illnesses rise across Florida, now is a good time to get vaccinated.

New U.S. bills would require food makers to label alpha-gal as a top allergen, plus increase funding for this fast-growing ...